Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain
Autor: | Ja-Kyeong Lee, Sung-Hwa Yoon, Hye-Kyung Lee, Hahnbie Lee, Seung Woo Kim, Il-Doo Kim, Ju-Young Park |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine medicine.drug_class Anti-Inflammatory Agents Pharmacology Neuroprotection Anti-inflammatory Brain Ischemia Rats Sprague-Dawley 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Parenchyma medicine Animals Pharmacology (medical) Pyruvates Microglia Cell adhesion molecule Infarction Middle Cerebral Artery NF-κB medicine.disease Rats Neuroprotective Agents 030104 developmental biology medicine.anatomical_structure chemistry Original Article Neurology (clinical) Pyruvic acid Infiltration (medical) 030217 neurology & neurosurgery |
Zdroj: | Neurotherapeutics. 16:523-537 |
ISSN: | 1878-7479 1933-7213 |
DOI: | 10.1007/s13311-019-00711-w |
Popis: | Ethyl pyruvate (EP) is a simple aliphatic ester of pyruvic acid and has been shown to have protective properties, which have been attributed to its anti-inflammatory, anti-oxidative, and anti-apoptotic functions. In an effort to develop better derivatives of EP, we previously synthesized DEOPA (N,N-diethyl-2-oxopropanamide, a novel isoster of EP) which has greater neuroprotective effects than EP, probably due to its anti-inflammatory and anti-excitotoxic effects. In the present study, we synthesized 3 DEOPA derivatives, in which its diethylamino group was substituted with diisopropylamino, dipropylamino, or diisobutylamino groups. Among them, DIPOPA (N,N-diisopropyl-2-oxopropanamide) containing diisopropylamino group had a greater neuroprotective effect than DEOPA or EP when administered intravenously to a rat middle cerebral artery occlusion (MCAO) model at 9 h after MCAO. Furthermore, DIPOPA had a wider therapeutic window than DEOPA and a marked reduction of infarct volume was accompanied by greater neurological and behavioral improvements. In particular, DIPOPA exerted robust anti-inflammatory effects, as evidenced by marked suppressions of microglia activation and neutrophil infiltration in the MCAO model, in microglial cells, and in neutrophil–endothelial cocultures at lower concentration, and did so more effectively than DEOPA. In particular, DIPOPA remarkably suppressed neutrophil infiltration into brain parenchyma, and this effect was attributed to the expressional inhibitions of cell adhesion molecules in neutrophils of brain parenchyma and in circulating neutrophils via NF-κB inhibition. Together, these results indicate the robust neuroprotective effects of DIPOPA are attributable to its anti-inflammatory effects and suggest that DIPOPA offers a potential therapeutic means of ameliorating cerebral ischemic injury and other inflammation-related pathologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13311-019-00711-w) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |